[go: up one dir, main page]

SE451850B - Sett att framstella ett glykoprotein med kend formaga att stimulera bildning och differentiering av humana granulocyter - Google Patents

Sett att framstella ett glykoprotein med kend formaga att stimulera bildning och differentiering av humana granulocyter

Info

Publication number
SE451850B
SE451850B SE8005256A SE8005256A SE451850B SE 451850 B SE451850 B SE 451850B SE 8005256 A SE8005256 A SE 8005256A SE 8005256 A SE8005256 A SE 8005256A SE 451850 B SE451850 B SE 451850B
Authority
SE
Sweden
Prior art keywords
medium
glycoprotein
csf
human
serum
Prior art date
Application number
SE8005256A
Other languages
English (en)
Swedish (sv)
Other versions
SE8005256L (sv
Inventor
F Takaku
K Ogasa
M Kuboyama
N Yanai
M Yamada
Y Watanabe
Original Assignee
Morinaga Milk Industry Co Ltd
Green Cross Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP9235579A external-priority patent/JPS5618591A/ja
Priority claimed from JP6462580A external-priority patent/JPS56160994A/ja
Application filed by Morinaga Milk Industry Co Ltd, Green Cross Corp filed Critical Morinaga Milk Industry Co Ltd
Publication of SE8005256L publication Critical patent/SE8005256L/
Publication of SE451850B publication Critical patent/SE451850B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE8005256A 1979-07-20 1980-07-18 Sett att framstella ett glykoprotein med kend formaga att stimulera bildning och differentiering av humana granulocyter SE451850B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9235579A JPS5618591A (en) 1979-07-20 1979-07-20 Production of substance capable of differentiation and multiplication of stem cells of human granulocyte
JP6462580A JPS56160994A (en) 1980-05-15 1980-05-15 Preparation of substance capable of differentiating and multiplying human granulocytic stem cell

Publications (2)

Publication Number Publication Date
SE8005256L SE8005256L (sv) 1981-01-21
SE451850B true SE451850B (sv) 1987-11-02

Family

ID=26405712

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8005256A SE451850B (sv) 1979-07-20 1980-07-18 Sett att framstella ett glykoprotein med kend formaga att stimulera bildning och differentiering av humana granulocyter

Country Status (7)

Country Link
US (1) US4342828A (de)
CA (1) CA1128881A (de)
CH (1) CH644520A5 (de)
DE (1) DE3027105A1 (de)
FR (1) FR2461500A1 (de)
GB (1) GB2058081B (de)
SE (1) SE451850B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6030654B2 (ja) * 1980-12-31 1985-07-17 株式会社林原生物化学研究所 ヒトコロニ−刺激因子の製造方法
DE3110611A1 (de) * 1981-03-18 1982-10-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen "mitogene der leukozyten und des entzuendungsgewebes:natuerliche leukopoetine zur selektiven anregung der teilung und differenzierung von leukozyten"
US4432751A (en) * 1982-03-05 1984-02-21 Baylor College Of Medicine Monoclonal antibodies against lens epithelial cells and preventing proliferation of remnant lens epithelial cells after extracapsular extraction
JPS59137417A (ja) * 1983-01-28 1984-08-07 Morinaga Milk Ind Co Ltd 人尿由来コロニ−形成刺激因子及びカリクレインの製造法
JPS61227526A (ja) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
UA29377C2 (uk) * 1984-09-19 2000-11-15 Новартіс Аг Спосіб отримання білка з активністю колонієстимулювального фактора гранулоцитів та макрофагів(gm-csf) приматів
US5837229A (en) * 1985-02-05 1998-11-17 Chiron Corporation Uses of recombinant colony stimulating factor-1
US6156300A (en) * 1985-02-05 2000-12-05 Chiron Corporation Point mutants of N∇2 CSF-1 and carboxy truncated fragments thereof
US5556620A (en) * 1985-02-05 1996-09-17 Cetus Oncology Corporation Use of recombinant colony stimulating factor-1 to enhance wound healing
US6146851A (en) * 1985-02-05 2000-11-14 Chiron Corporation DNA encoding NV2 (long form) and carboxy truncated fragments thereof
US5422105A (en) * 1985-02-05 1995-06-06 Cetus Oncology Corporation Use of recombinant colony stimulating factor 1
US5792450A (en) * 1985-02-05 1998-08-11 Chiron Corporation Purified human CSF-1
EP0209601B1 (de) * 1985-02-05 1993-12-15 Cetus Oncology Corporation Rekombinanter koloniestimulierender faktor-1
US4847201A (en) * 1985-02-05 1989-07-11 Cetus Corporation DNA encoding for CSF-1 and accompanying recombinant systems
US5573930A (en) * 1985-02-05 1996-11-12 Cetus Oncology Corporation DNA encoding various forms of colony stimulating factor-1
US5104650A (en) * 1985-02-05 1992-04-14 Cetus Corporation Uses of recombinant colony stimulating factor-1
JPH0753667B2 (ja) * 1985-08-09 1995-06-07 新技術開発事業団 骨髄移植療法補助剤
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US4721096A (en) * 1986-04-18 1988-01-26 Marrow-Tech Incorporated Process for replicating bone marrow in vitro and using the same
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5160490A (en) * 1986-04-18 1992-11-03 Marrow-Tech Incorporated Three-dimensional cell and tissue culture apparatus
US4963489A (en) * 1987-04-14 1990-10-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5032508A (en) * 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5510254A (en) * 1986-04-18 1996-04-23 Advanced Tissue Sciences, Inc. Three dimensional cell and tissue culture system
US5266480A (en) * 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US5055291A (en) * 1986-11-04 1991-10-08 Baylor College Of Medicine Compositions for preventing secondary cataracts
US4871350A (en) * 1986-11-04 1989-10-03 Baylor College Of Medicine Methods and compositions for preventing secondary cataracts
JPS63245667A (ja) * 1987-03-31 1988-10-12 Ube Ind Ltd 肥満細胞成長活性を有するヒトｉｌ−３産生ヒト細胞および肥満細胞成長活性を有するヒトｉｌ−３の製造方法
AU625807B2 (en) * 1987-09-22 1992-07-16 Novartis Vaccines And Diagnostics, Inc. Uses of recombinant colony stimulating factor-1
US5190876A (en) * 1988-12-27 1993-03-02 Emory University Method of modifying cellular differentiation and function and compositions therefor
CA2080693C (en) * 1990-04-24 2001-11-27 Mark Eisenberg Composite living skin equivalents
US5652337A (en) * 1991-03-11 1997-07-29 Creative Biomolecules, Inc. OP-3-induced morphogenesis
US6211146B1 (en) 1991-03-11 2001-04-03 Curis, Inc. 60A protein-induced morphogenesis
CA2363965C (en) 1991-03-11 2010-05-18 Curis, Inc. Protein-induced morphogenesis
US5436151A (en) * 1992-04-03 1995-07-25 Regents Of The University Of Minnesota Method for culturing human hematopoietic stem cells in vitro
US5460964A (en) * 1992-04-03 1995-10-24 Regents Of The University Of Minnesota Method for culturing hematopoietic cells
IL110195A (en) * 1994-07-03 2003-10-31 David Danon Method and system for cultivating macrophages
US6498142B1 (en) 1996-05-06 2002-12-24 Curis, Inc. Morphogen treatment for chronic renal failure
DE69826854T2 (de) 1997-05-05 2006-02-02 Curis, Inc., Cambridge Therapien zur behandlung von akutem nierenversagen
US8435939B2 (en) * 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
US7423007B2 (en) 2002-08-27 2008-09-09 Biokine Therapeutics Ltd. Cxcr4 antagonist and use thereof
US8029985B2 (en) * 2004-09-01 2011-10-04 Vybion, Inc. Amplified bioassay
EP2104507A4 (de) * 2006-12-21 2011-05-25 Biokine Therapeutics Ltd T-140 peptid-analoga mit cxcr4 superagonisten-aktivität für die krebstherapie
WO2010092571A2 (en) 2009-02-11 2010-08-19 Yeda Research And Development Co. Ltd. Short beta-defensin-derived peptides
EP2442822B1 (de) 2009-06-14 2014-03-05 Biokine Therapeutics Ltd. Peptidtherapie zum steigern der blutplättchenwerte
WO2013160895A1 (en) 2012-04-24 2013-10-31 Biokine Therapeutics Ltd. Peptides and use thereof in the treatment of large cell lung cancer
EP3943098A3 (de) 2015-07-16 2022-05-11 Biokine Therapeutics Ltd. Zusammensetzungen und verfahren zur behandlung von krebs
BR112018016924A2 (pt) 2016-02-23 2019-01-02 Biokine Therapeutics Ltd método de seleção de regime de tratamento para indivíduo que tem leucemia mieloide aguda (lma), método de maximização de resposta ao tratamento de leucemia mieloide aguda (lma), método de tratamento de lma, antagonista de cxcr4 e agente quimioterápico no tratamento de lma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4135975A (en) * 1977-12-14 1979-01-23 Lichtman Marshall A Obtaining human cell lines that elaborate colony stimulating activity for marrow cells of man and other species and methods of preparing same
SE451844B (sv) * 1978-03-20 1987-11-02 Morinaga Milk Industry Co Ltd Glykoprotein, forfarande for framstellning derav samt terapeutiskt medel innehallande nemnda glykoprotein
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤

Also Published As

Publication number Publication date
FR2461500A1 (fr) 1981-02-06
DE3027105C2 (de) 1988-08-25
FR2461500B1 (de) 1984-02-17
SE8005256L (sv) 1981-01-21
CA1128881A (en) 1982-08-03
GB2058081B (en) 1983-02-09
CH644520A5 (de) 1984-08-15
US4342828A (en) 1982-08-03
GB2058081A (en) 1981-04-08
DE3027105A1 (de) 1981-02-12

Similar Documents

Publication Publication Date Title
SE451850B (sv) Sett att framstella ett glykoprotein med kend formaga att stimulera bildning och differentiering av humana granulocyter
CA1068601A (en) Fibrinogen-free plasminogen-plasmin-free plasma and method of preparing and using same
Nicola et al. Preparation of colony stimulating factors from human placental conditioned medium
Burke The purification of interferon
US4482485A (en) Method of preparation of human urine origin colony-stimulating factor and kallikrein
FI72143B (fi) Foerfarande foer framstaellning av maenniskointerferon
CA1063019A (en) Extracts of the haemopoietic system
Lehmann et al. Haemoglobin E in Burmese
Coyne et al. Guinea Pig Lymphotoxin (LT) II. Physicochemical Properties of LT Produced by Lymphocytes Stimulated with Antigen or Concanavalin A: Its Differentiation from Migration-Inhibitory Factor (MIF)
US3975344A (en) Interferon purification
CN113789319B (zh) 从蝇蛆中分离蛆激酶的方法及应用
Hammar et al. Induction of tubuloreticular structures in cultured human endothelial cells by recombinant interferon alfa and beta
CN113801219A (zh) 一种转铁蛋白的制备方法及包含转铁蛋白的组合物和应用
CN110724176B (zh) 一种治疗阿尔茨海默症的血浆蛋白分离物及其制备方法和应用
CN110787187B (zh) 一种增强记忆力和提高认知功能的血浆混合物及其制备方法和应用
SE451844B (sv) Glykoprotein, forfarande for framstellning derav samt terapeutiskt medel innehallande nemnda glykoprotein
JP2787220B2 (ja) ウィルス感染防御剤
US3629235A (en) Process for isolating an interferon inducer and the product per se
JPS6041615A (ja) コロニ−形成刺激因子の製造方法
HRP20140247T1 (hr) Cjepivo protiv raka
AT391482B (de) Verfahren zur industriellen herstellung von hochreinem menschlichem leukozyteninterferon
JPS6237605B2 (de)
EP0407092A1 (de) Lymphozyten aktivierender Faktor, Verfahren zu seiner Herstellung und Verfahren zur Vermehrung von antikörperbildenden Lymphozyten und Antikörperherstellung unter Anwendung dieses Faktors
JP4581082B2 (ja) 自己免疫増強剤、その製造方法及びそれを用いた化粧料
Kutsky GROWTH-STIMULATING EFFECTS BY NUCLEO-PROTEIN AND CELL FRACTIONS ON CHICK HEART FIBROBLASTS IN VITRO

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8005256-6

Effective date: 19940210

Format of ref document f/p: F